Mobile

The trial is designed to determine the safety and efficacy of ABP 501 compared with Adalimumab in subjects with moderate to severe rheumatoid arthritis

Update Il y a 4 ans
Reference: EUCTR2013-000525-31

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective for this study is to assess the efficacy of ABP 501 compared with adalimumab.

Inclusion criteria

  • Moderate to Severe Rheumatoid Arthritis

Links